Vanda Pharmaceuticals Stock
Price
Target price
€5.05
€5.05
-1.940%
-0.1
-1.940%
€5.00
14:26 / Tradegate
WKN: A0JJT3 / Symbol: VNDA / Name: Vanda Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vanda Pharmaceuticals Stock
We can see a decrease in the price for Vanda Pharmaceuticals. Compared to yesterday it has lost -€0.100 (-1.940%).
Currently there is a rather positive sentiment for Vanda Pharmaceuticals with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 5 € is below the current price of 5.05 € for Vanda Pharmaceuticals, so the potential is actually -0.99%.
So far the community has only identified positive things for Vanda Pharmaceuticals stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | -1.940% | 9.574% | 34.817% | -10.435% | 32.732% | -64.966% | - |
| Ardelyx Inc. | 0.340% | -5.213% | 13.498% | 74.307% | 23.945% | 27.929% | - |
| Evolus Inc | -1.680% | -1.681% | 5.405% | 27.174% | 29.282% | 59.184% | - |
| Salarius Pharmaceuticals Inc. | 0.530% | -7.729% | -10.748% | -66.491% | -31.171% | -98.449% | -99.993% |
Comments
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for VNDA provided by MarketBeat